YFM Equity Partners (YFM) has invested in MurphyCobb & Associates (MCA), a London-headquartered advertising production consultancy with operations in 38 countries.
Thompson Street Capital Partners (TSCP), a St Louis-based private equity firm, has sold its portfolio company, DDC Solutions, to Daikin Applied, a subsidiary of Japan-headquartered HVAC manufacturer Daikin Industries.
TPG has announced a strategic partnership with Vanara Capital, a newly launched investment management firm focused on growth-stage technology opportunities, according to a report by Bloomberg.
Continuation vehicles (CVs) are becoming a defining feature of private equity exit strategies, with implications that could fundamentally reshape the industry’s traditional buyout model, according to a report by Bloomberg citing new research from Schroders Capital, the private assets division of Schroders.
Bain Capital and Cinven are resuming IPO preparations for German pharmaceutical company Stada Arzneimittel, following a pause in sale discussions with CapVest Partners, according to a report by Bloomberg citing sources familiar with the matter.
Switzerland has emerged as one of Europe’s most active M&A markets in 2025, with deal volumes surging over 465% year-to-date to $16.7bn driven in part by significant private equity dealmaking, according to a report by Bloomberg.
Rainier Partners-backed Wilmar has acquired EZRED, a designer, manufacturer, and distributor of lighting, tool organisation, and hand tools for the automotive aftermarket.
Hospitality-focused private investment firm Noble Investment Group, has hired Marc Dober as Senior Director of Asset Management, to focus on driving asset performance, operational efficiencies, revenue growth, and long-term value creation across the firm’s portfolio.
Chicago-based Pritzker Private Capital has closed its fourth fund PPC IV with $3.4bn in capital commitments from mix of institutional investors across North America, Europe, Asia, and Latin America, surpassing its $3bn target, according to a report by Bloomberg.
India’s Aurobindo Pharma has emerged as the frontrunner to acquire Prague-based generics manufacturer Zentiva from Advent International in a deal valued at up to $5.5bn, in what would be one of the largest European healthcare exits of the year, according to a report by the Economic Times.
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
